Beacon Biosignals is mapping the brain during sleep
Beacon Biosignals, founded by MIT alumnus Jake Donoghue and former MIT researcher Jarrett Revels, is developing an AI-powered platform that uses at-home EEG data collected during sleep to improve the diagnosis and treatment of brain disorders. The company's lightweight headband enables continuous, clinical-grade brain monitoring outside traditional sleep labs, supporting drug development and longitudinal brain health research. Beacon has partnered with pharmaceutical companies and deployed its FDA-cleared device in over 40 global clinical trials for conditions like Alzheimer’s, Parkinson’s, and major depressive disorder.
- ▪Beacon Biosignals was founded by Jake Donoghue PhD ’19 and former MIT researcher Jarrett Revels.
- ▪The company uses a lightweight EEG headband to collect brain activity data while people sleep at home.
- ▪Its AI-driven platform processes EEG data to support diagnostics, drug development, and patient cohort identification.
- ▪Beacon’s FDA 510(k)-cleared device has been used in more than 40 clinical trials worldwide.
- ▪The company aims to build a 'foundation model' of the brain by aggregating large-scale, longitudinal sleep EEG data.
Opening excerpt (first ~120 words) tap to expand
Founded by Jake Donoghue PhD ’19 and former MIT researcher Jarrett Revels, the company is creating an AI-driven platform to help diagnose and treat disease. Zach Winn | MIT News Publication Date: May 1, 2026 Press Inquiries Press Contact: Abby Abazorius Email: [email protected] Phone: 617-253-2709 MIT News Office Media Download ↓ Download Image Caption: Beacon Biosignals is creating a model to help diagnose and treat brain disorders, based on data collected while people sleep at home. The firm was founded by MIT alumnus Jake Donoghue and former MIT researcher Jarrett Revels.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at MIT News.